Gene: FLYWCH1
Official Full Name: FLYWCH-type zinc finger 1provided by HGNC
Gene Summary: Enables transcription coactivator binding activity and transcription corepressor activity. Involved in DNA damage response and negative regulation of transcription by RNA polymerase II. Located in cytosol; nuclear body; and pericentric heterochromatin. Part of transcription regulator complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03314 | FLYWCH1 Knockout cell line (HeLa) | Human | FLYWCH1 | 1:3~1:6 | Negative | Online Inquiry |
KO03315 | FLYWCH1 Knockout cell line (HCT 116) | Human | FLYWCH1 | 1:2~1:4 | Negative | Online Inquiry |
KO03316 | FLYWCH1 Knockout cell line (HEK293) | Human | FLYWCH1 | 1:3~1:6 | Negative | Online Inquiry |
KO03317 | FLYWCH1 Knockout cell line (A549) | Human | FLYWCH1 | 1:3~1:4 | Negative | Online Inquiry |
FLYWCH1 Gene Knockout Cell Lines are a cutting-edge tool designed for researchers investigating the FLYWCH1 gene's role in cellular processes and disease mechanisms. These cell lines are genetically modified to have a complete knockout of the FLYWCH1 gene, thereby providing a powerful platform for functional studies. By eliminating the gene's expression, researchers can study the downstream effects on cellular functions, signaling pathways, and gene regulatory networks, thereby uncovering vital insights into its biological significance.
The key mechanism behind the FLYWCH1 Gene Knockout Cell Lines involves targeted genome editing, typically utilizing technologies such as CRISPR-Cas9. This method allows for precise deletion of the FLYWCH1 gene, which facilitates the analysis of phenotypic changes in cellular behavior compared to wild-type cells. By using these knockout models, scientists can elucidate the role of FLYWCH1 in various biological pathways, including its implications in cancer, neurobiology, and developmental processes.
The scientific importance of the FLYWCH1 Gene Knockout Cell Lines extends to both research and clinical applications. In a research context, these cell lines can aid in understanding how the loss of FLYWCH1 affects cellular processes, which may lead to novel therapeutic targets or biomarker discoveries. Clinically, insights gained from these models can inform drug development strategies and potential interventions in diseases where FLYWCH1 is implicated.
What sets FLYWCH1 Gene Knockout Cell Lines apart from alternatives is their validated creation and specificity for the FLYWCH1 gene, ensuring that they provide reliable data. Unlike less targeted approaches that may lead to off-target effects or variable results, these knockout lines offer reproducibility and confidence in experimental outcomes.
For researchers, clinicians, and biologists, the value of FLYWCH1 Gene Knockout Cell Lines is multifold. They provide an indispensable resource for conducting high-impact research that can translate into real-world applications, enhancing the understanding of genetic regulation and disease mechanisms. Our company has a proven track record in developing precision gene editing tools and high-quality cell lines, positioning us as a trusted partner in advancing biological research and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.